TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Presented positive updated data from the ALLOHA™ Phase 1 heme trial at…
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00…
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated…
THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS
Strong share gains and solid growth; operating leverage and cashflow drive deleveragingZURICH,…
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
February 24, 2026 16:30 ET | Source: Cardiff Oncology, Inc. Reported positive…
Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb.…
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position…
GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif.,…
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
